Does Gemtuzumab/Gemtuzumab (MYLOTARG) need to be used in combination with other drugs?

Whether the use of Gemtuzumab/Gemtuzumab (MYLOTARG) needs to be combined with other drugs depends on the patient's specific situation and the doctor's treatment plan. Typically, Gemtuzumab/Gemtuzumab can be used as monotherapy, especially in AML treatment-naïve or relapsed patients.

However, sometimes doctors may choose to combine gemtuzumab/gemtuzumab with other treatments to enhance the effectiveness of the treatment or to target specific subtypes of AML. The specific combination and regimen of combination therapy will vary based on the patient's age, subtype of AML, severity of disease, and the patient's overall health.

Some drugs that may be used in combination with Gemtuzumab/Gemtuzumab include chemotherapy drugs, other targeted therapy drugs, and hematopoietic stem cell transplantation. The formulation of treatment plans requires comprehensive consideration of a variety of factors and individualized adjustments based on the patient's specific circumstances.

Therefore, if you or someone you know is considering gemtuzumab/gemtuzumabtreatment for AML, it is recommended to discuss the treatment options in detail with your doctor and understand whether other drugs may need to be used in combination to obtain the best treatment effect. The doctor will be able to develop the most appropriate treatment plan based on the patient's condition and provide detailed recommendations.

Gemtuzumab/GemtuzumabIt is not currently on the market in China, so it cannot be included in medical insurance. Patients cannot purchase it domestically and need to purchase it through overseas channelsGemtuzumab/Gemtuzumab. Overseas Gemtuzumab/Gemtuzumab only has Pfizer’s original drug, which is expensive. The cheaper ones are mainly Turkish original drugs, which cost around 45,000 yuan, and Hong Kong’s original drugs, which cost 65,000 It’s about RMB 1,000, and the ingredients and efficacy of the original drug are consistent.